HILDEN , Germany and BEVERLY, Massachusetts , January 11, 2015 /PRNewswire/ --
Enzymatics products used in 80% of all global NGS sequencing reactions Strengthens QIAGEN's universal NGS product offering and strategy to offer complete NGS workflows from sample to insight Adds comprehensive R&D, manufacturing, formulation and analytical capabilities in enzymology Strategic partnership formed with ArcherDX, including technology and distribution rights to proprietary Archer NGS panel technology QIAGEN reaffirms fourth-quarter and full-year 2014 adjusted net sales guidance; charges to be taken related to acquisition and other restructuring activities QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Prime Standard QIA) today announced the acquisition of the Enzyme Solutions Unit of Enzymatics, a world leader in the development, manufacturing, and OEM supply of enzymes essential
Burlington Stores, Inc. (NYSE:BURL), a nationally recognized off-price
retailer of high-quality, branded apparel at everyday low prices, today
announced the resignation and retirement of Todd Weyhrich, the Company’s
Executive Vice President and Chief Financial Officer and the promotion
of Marc Katz, currently Executive Vice President of Merchandise Support
and Information Technology to Executive Vice President and Chief
Financial Officer, effective January 12, 2015.
National scholarship fund TheDream.US announced
today that The
Pershing Square Foundation (PSF) has made a $10 million commitment
over three years to provide DREAMers the opportunity to pursue their
Ben Franklin Financial, Inc. (the “Company”), the proposed stock holding
company for Ben Franklin Bank of Illinois (the “Bank”), announced
preliminary results of the stock offering conducted in connection with
the mutual-to-stock conversion of Ben Franklin Financial, MHC.
SHORT HILLS, NJ--(Marketwired - January 08, 2015) - Dun & Bradstreet (NYSE: DNB), the world's leading source of commercial information and insight on businesses, today announced that it has acquired NetProspex, the Massachusetts-based company that is a leader in B2B professional contact data and data management.
Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security
with a new layer of protection designed specifically for physical and
virtual data centers, today announced that it will issue a press release
reporting financial results for the fourth quarter and full year ended
December 31, 2014 after the close of the market on February 5, 2015.
plc (NYSE:COV) today announced it has received CE Mark approval for its
Stellarex™ drug-coated angioplasty balloon (DCB). The Stellarex™ DCB is
used to restore and maintain blood flow to the arteries of the leg in
patients with peripheral arterial disease (PAD).
The Stellarex™ DCB is inserted into the diseased artery and inflated to
open the vessel and restore blood flow, while a drug called paclitaxel
is deposited onto the vessel wall to prevent the reoccurrence of new
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.